CK Life Sciences International, the biotech unit controlled by the Li Ka-shing family, is expected to post a loss for last year due to an increase in R&D spending and a decline in the value of its ...

Dogwood Therapeutics, Inc. has announced that its largest shareholder, CK Life Sciences Int’l. (via its subsidiary Conjoint Inc.), is converting an outstanding $19.5 million loan into preferred ...

Therapeutics announces that its largest shareholder, CK Life Sciences has agreed, through its wholly-owned subsidiary, Conjoint, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CK Life Sciences Int’l., (Holdings), Inc. (“CKLS”) has agreed, through its wholly-owned subsidiary, Conjoint Inc. (“Conjoint”), to assign to the Company all outstanding indebtedness ...

Largest shareholder, CK Life Sciences Int’l., (Holdings) Inc. agrees to conversion of debt into equity, removing all existing debt from Dogwood’s balance sheet ATLANTA, March 12, 2025 (GLOBE ...

The company’s main investor, CK Life Sciences Int’l., (Holdings), Inc., through its subsidiary Conjoint Inc., has converted a $19.5 million loan, along with accrued interest, into preferred ...

(MENAFN- GlobeNewsWire - Nasdaq) Largest shareholder, CK Life Sciences Int'l., (Holdings) Inc. agrees to conversion of debt into equity, removing all existing debt from Dogwood's balance sheet ...